- Conditions
- Cervical Mucus
- Interventions
- Gonadotropin Releasing Hormone Antagonists Relugolix
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 21 Years to 40 Years · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Portland, Oregon
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Infertility, Miscarriage
- Interventions
- Creighton Model System in conjunction with Natural Procreative Technology (NPT)
- Other
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 834 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2020
- U.S. locations
- 5
- States / cities
- Baton Rouge, Louisiana • Gardner, Massachusetts • St Louis, Missouri + 2 more
- Conditions
- Pregnancy, Fertility
- Interventions
- Creighton Model System of Natural Family Planning
- Behavioral
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 624 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2013
- U.S. locations
- 17
- States / cities
- Sacramento, California • Duluth, Minnesota • Saint Paul, Minnesota + 13 more
- Conditions
- Fertility, Contraception
- Interventions
- Leuprolide acetate, Estrogen and Progesterone Replacement, Progestin
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 21 Years to 40 Years · Female only
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Fertility
- Interventions
- Kegg
- Device
- Lead sponsor
- Lady Technologies Inc
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 189 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Contraception
- Interventions
- Norgestrel 0.075 mg
- Drug
- Lead sponsor
- HRA Pharma
- Industry
- Eligibility
- 18 Years to 35 Years · Female only
- Enrollment
- 52 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 2
- States / cities
- Sacramento, California • Portland, Oregon